Literature DB >> 26475960

The performance of Dynamic Spectral Imaging colposcopy depends on indication for referrals.

J A Louwers1, A Zaal2, M Kocken3, J Berkhof4, E Papagiannakis5, P J F Snijders3, C J L M Meijer3, R H M Verheijen2.   

Abstract

OBJECTIVE. A previous study has shown that Dynamic Spectral Imaging (DSI) colposcopy increases the sensitivity of the colposcopic examination in women referred with abnormal cytology. In this study we have reanalyzed the performance of DSI and conventional colposcopy for new referral conditions and for low-grade cytology referrals versus high-grade cytology referrals. METHOD. Data from a previous validation trial was used to assess the performance of DSI in different cytology groups:Women referred with BMD (borderline and mild dyskaryosis) cytology and women referred with NBMD cytology either hrHPV positive or negative were separately analyzed. Furthermore, we tried to assess the clinical performance by appropriate filtering of patients to replicate two different referral strategies. RESULTS. The sensitivity of DSI and conventional colposcopy to detect CIN2+ lesions in women referred with BMD cytology is 82% and 44% respectively (p= 0.001) and in the NBMD group 77% and 64% respectively (p= 0.24). If the two techniques are combined the sensitivity is 85%.When the conditions of new screening strategies are applied DSI colposcopy has a higher sensitivity to detect CIN2+ than conventional colposcopy. Findings are similar when CIN3+ is used as a threshold. CONCLUSION. We found that in most cases DSI colposcopy has a higher sensitivity than conventional colposcopy, even when referral criteria are changed. Unlike conventional colposcopy, the sensitivity of colposcopy with DSI in low-grade cytology referrals was found similar to the sensitivity in high-grade cytology referrals. This suggests that a baseline colposcopy sensitivity may be possible with the adjunctive use of the DSI map, irrespective of referral cytology.

Entities:  

Keywords:  CIN; Cervix uteri; Colposcopy; Dynamic Spectral Imaging; Premalignant lesion; Sensitivity and specificity

Mesh:

Substances:

Year:  2015        PMID: 26475960     DOI: 10.1016/j.ygyno.2015.10.009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Increased detection of precancerous cervical lesions with adjunctive dynamic spectral imaging.

Authors:  Sara A DeNardis; Philip T Lavin; Jeff Livingston; William R Salter; Nanette James-Patrick; Emmanouil Papagiannakis; Christopher G Olson; Lori Weinberg
Journal:  Int J Womens Health       Date:  2017-09-28

2.  Optimization of Classification Strategies of Acetowhite Temporal Patterns towards Improving Diagnostic Performance of Colposcopy.

Authors:  Karina Gutiérrez-Fragoso; Héctor Gabriel Acosta-Mesa; Nicandro Cruz-Ramírez; Rodolfo Hernández-Jiménez
Journal:  Comput Math Methods Med       Date:  2017-07-04       Impact factor: 2.238

3.  Label-free, High-Resolution Optical Metabolic Imaging of Human Cervical Precancers Reveals Potential for Intraepithelial Neoplasia Diagnosis.

Authors:  Dimitra Pouli; Hong-Thao Thieu; Elizabeth M Genega; Laura Baecher-Lind; Michael House; Brian Bond; Danielle M Roncari; Megan L Evans; Francisca Rius-Diaz; Karl Munger; Irene Georgakoudi
Journal:  Cell Rep Med       Date:  2020-05-19

4.  Can the dynamic spectral imaging (DSI) color map improve colposcopy examination for precancerous cervical lesions? A prospective evaluation of the DSI color map in a multi-biopsy clinical setting.

Authors:  Berit Bargum Booth; Lone Kjeld Petersen; Jan Blaakaer; Tonje Johansen; Henrik Mertz; Katja Dahl; Pinar Bor
Journal:  BMC Womens Health       Date:  2021-01-12       Impact factor: 2.809

5.  Dynamic Spectral Imaging Colposcopy Versus Regular Colposcopy in Women Referred With High-Grade Cytology: A Nonrandomized Prospective Study.

Authors:  Berit Bargum Booth; Lone Kjeld Petersen; Jan Blaakaer; Tonje Johansen; Henrik Mertz; Christina Blach Kristensen; Søren Lunde; Katja Dahl; Pinar Bor
Journal:  J Low Genit Tract Dis       Date:  2021-04-01       Impact factor: 3.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.